skip to Main Content

Calcium Channel Blockers May Improve Chemotherapy Response

Newsfeed image, light gray text on dark gray background
Calcium channel blockers may improve treatment for pancreatic cancer patients receiving gemcitabine-based chemotherapy, according to recent findings published in the Proceedings of the National Academy of Sciences.

“These exciting data suggest that the addition of a calcium channel blocker to gemcitabine may have some benefits, especially since calcium channel blockers have a very favorable toxicity profile, are low cost and are readily available,” said Thao Pham, PhD, research assistant professor of Medicine in the Division of Hematology and Oncology and a co-author of the study. Hidayatullah Munshi, MD, the Robert and Lora Lurie Professor of Medicine, was also a co-author of the study. Read more . . . 


Back To Top